** Shares of Proteomics International Laboratories surge as much as 24% to A$0.750, their biggest one-day pct gain since Oct. 8

** Medical technology firm reports that its PromarkerEndo plasma protein biomarker panel accurately identifies all stages of endometriosis

** Endometriosis is a condition causing uterine-like tissue growth outside the uterus, affecting roughly 10% of reproductive age women and girls according to the WHO

** The condition takes an average of seven years to diagnose

** PIQ sets sights on Q2 CY25 for Australian launch of its product

** Stock hits its highest level since Oct. 29

** Including session's moves, stock trims YTD losses to 19% as of 0050 GMT

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com;))